Recent studies have shown that elevated expression of MCM3 in tumor tissues of hepatocellular carcinoma patients predicted worse overall survival [41], while RPA1 being demonstrated as a candidate oncogene which influences tumor biological behaviors in many cancers including colon cancer [42]. This evidence concerns the gene MCM3 and hepatocellular carcinoma.